Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Sep-20 5:13 PM View:  | Minerva Neurosciences, Inc. (NERV) | 10-Sep-20 | Market Purchase | 7,000 | $2.97 | $20,790.00 | 53% 13.33K to 20.33K | (17%) |
| 27-Jun-19 4:30 PM View: | Minerva Neurosciences, Inc. (NERV) | 26-Jun-19 | Market Purchase | 10,000 | $5.37 | $53,700.00 | 300% 3.33K to 13.33K | (54%) |
| 22-Feb-19 9:33 PM View: | Amarin Corp Plc\uk (AMRN) | 22-Feb-19 | Option Exercise | 192,347 | $4.46 | $857,170.00 | 763% 25.2K to 217.55K | |
| 22-Feb-19 9:33 PM View: | Amarin Corp Plc\uk (AMRN) | 22-Feb-19 | Market Option Sale | 192,347 | $20.02 | $3,850,520.00 | (88%) 217.55K to 25.2K | |
| 22-Feb-19 9:33 PM View: | Amarin Corp Plc\uk (AMRN) | 22-Feb-19 | Market Sale | 11,035 | $20.02 | $220,905.00 | (44%) 25.2K to 14.17K | |
| 09-Jul-14 7:58 PM View: | Minerva Neurosciences, Inc. (NERV) | 01-Jul-14 | Purchase | 3,333 | $6.00 | $19,998.00 | 100% 0 to 3.33K | |
| 11-Jul-13 6:59 AM View: | Amarin Corp Plc\uk (AMRN) | 10-Jul-13 | Grant | 1,755 | $5.59 | $9,810.45 | 7% 23.45K to 25.2K | 212% |
| 15-Apr-13 8:44 AM View: | Amarin Corp Plc\uk (AMRN) | 10-Apr-13 | Grant | 1,329 | $7.38 | $9,808.02 | 6% 22.12K to 23.45K | 136% |
| 14-Jan-13 7:08 AM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-13 | Grant | 948 | $8.37 | $7,934.76 | 4% 21.17K to 22.12K | 108% |
| 12-Oct-12 8:32 AM View: | Amarin Corp Plc\uk (AMRN) | 10-Oct-12 | Grant | 708 | $11.20 | $7,929.60 | 3% 20.46K to 21.17K | 56% |
| 12-Jul-12 6:36 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jul-12 | Grant | 551 | $14.40 | $7,934.40 | 3% 19.91K to 20.46K | 21% |
| 12-Apr-12 7:46 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Apr-12 | Grant | 848 | $9.35 | $7,928.80 | 4% 19.06K to 19.91K | 86% |
| 12-Jan-12 6:07 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-12 | Grant | 894 | $7.06 | $6,311.64 | 5% 18.17K to 19.06K | 147% |
| 18-Oct-11 6:34 PM View: | Amarin Corp Plc\uk (AMRN) | 11-Oct-11 | Grant | 666 | $9.47 | $6,307.02 | 4% 17.5K to 18.17K | 84% |
| 13-Jul-11 5:27 PM View: | Amarin Corp Plc\uk (AMRN) | 11-Jul-11 | Grant | 445 | $14.18 | $6,310.10 | 3% 17.06K to 17.5K | 23% |
| 27-Apr-11 6:44 PM View: | Amarin Corp Plc\uk (AMRN) | 25-Apr-11 | Option Exercise | 30,000 | $1.03 | $30,900.00 | 184% 16.32K to 46.32K | |
| 27-Apr-11 6:44 PM View: | Amarin Corp Plc\uk (AMRN) | 25-Apr-11 | Market Option Sale | 30,000 | $16.58 | $497,379.00 | (65%) 46.32K to 16.32K | (5%) |
| 20-Apr-11 7:41 PM View: | Amarin Corp Plc\uk (AMRN) | 18-Apr-11 | Option Exercise | 3,000 | $1.03 | $3,090.00 | 16% 19.32K to 22.32K | |
| 20-Apr-11 7:41 PM View: | Amarin Corp Plc\uk (AMRN) | 18-Apr-11 | Market Option Sale (Planned) | 3,000 | $16.51 | $49,530.00 | (13%) 22.32K to 19.32K | (5%) |
| 16-May-11 9:25 PM View: | Amarin Corp Plc\uk (AMRN) | 11-Apr-11 | Grant | 742 | $8.50 | $6,307.00 | 5% 16.32K to 17.06K | 105% |
| 11-Feb-11 11:27 AM View: | Amarin Corp Plc\uk (AMRN) | 09-Feb-11 | Grant | 685 | -- | -- | 4% 18.63K to 19.32K | |
| 17-Dec-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Dec-03 | Option Exercise | 10,800 | $46.24 | $499,392.00 | 35% 31.15K to 41.95K | 14% |
| 17-Dec-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Dec-03 | Market Option Sale | 10,800 | $47.36 | $511,512.00 | (26%) 41.95K to 31.15K | (11%) |
| 21-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Oct-03 | Option Exercise | 112,399 | $26.08 | $2,931,320.00 | 943% 11.92K to 124.32K | |
| 21-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Oct-03 | Option Exercise | 215,233 | $29.55 | $6,360,820.00 | 173% 124.32K to 339.56K | |
| 21-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Oct-03 | Market Option Sale | 112,399 | $50.36 | $5,660,410.00 | (33%) 339.56K to 227.16K | (5%) |
| 21-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 17-Oct-03 | Market Option Sale | 196,010 | $50.36 | $9,871,060.00 | (86%) 227.16K to 31.15K | (5%) |
| 02-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 01-Oct-03 | Option Exercise | 25,000 | $7.27 | $181,750.00 | 242% 10.34K to 35.34K | |
| 02-Oct-03 10:00 PM View: | Genzyme Corp. (GENZ) | 01-Oct-03 | Market Option Sale (Planned) | 25,000 | $46.41 | $1,160,250.00 | (71%) 35.34K to 10.34K | (14%) |
| 03-Sep-03 10:00 PM View: | Genzyme Corp. (GENZ) | 02-Sep-03 | Option Exercise | 25,000 | $7.27 | $181,750.00 | 242% 10.34K to 35.34K | |
| 03-Sep-03 10:00 PM View: | Genzyme Corp. (GENZ) | 02-Sep-03 | Market Option Sale (Planned) | 25,000 | $47.25 | $1,181,200.00 | (71%) 35.34K to 10.34K | (12%) |
| 04-Aug-03 10:00 PM View: | Genzyme Corp. (GENZ) | 01-Aug-03 | Option Exercise | 25,000 | $7.27 | $181,750.00 | 242% 10.33K to 35.33K | |
| 04-Aug-03 10:00 PM View: | Genzyme Corp. (GENZ) | 01-Aug-03 | Market Option Sale (Planned) | 25,000 | $50.04 | $1,251,000.00 | (71%) 35.33K to 10.33K | (5%) |